OPTIMAL BALANCE PHARMACY

FDA Regulatory Profile

OPTIMAL BALANCE PHARMACY appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0851-2026, Class I) was initiated on August 5, 2026.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0851-2026Class IGlutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid,August 5, 2026